Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Total Current Liabilities of $281.9 million in Q1 2026, little changed quarter-over-quarter from $282.4 million in Q4 2025, and up 5.77% on a YoY basis from $266.5 million in Q1 2025.
Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health's Total Current Liabilities history runs 14 years deep, the most recent figure standing at $281.9 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 5.77% year-over-year to $281.9 million; the TTM figure through Mar 2026 stood at $281.9 million (up 5.77% YoY), while the FY2025 annual figure was $293.5 million, up 43.76% from the prior year.
- Total Current Liabilities was $281.9 million for Q1 2026 at Phibro Animal Health, roughly flat from $282.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $293.5 million in Q2 2025 to a low of $165.3 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $212.8 million across 5 years, with a median of $189.1 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities declined 11.65% in 2023, then surged 52.71% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $167.6 million in 2022, then climbed by 12.03% to $187.7 million in 2023, then increased by 24.24% to $233.2 million in 2024, then rose by 21.06% to $282.4 million in 2025, then slipped by 0.18% to $281.9 million in 2026.
- The last three Total Current Liabilities figures came in at $281.9 million (Q1 2026), $282.4 million (Q4 2025), and $270.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 281.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281.87 Mn |
| Dec 31, 2025 | 282.37 Mn |
| Sep 30, 2025 | 270.14 Mn |
| Jun 30, 2025 | 293.47 Mn |
| Mar 31, 2025 | 266.48 Mn |
| Dec 31, 2024 | 233.25 Mn |
| Sep 30, 2024 | 176.89 Mn |
| Jun 30, 2024 | 204.15 Mn |
| Mar 31, 2024 | 189.07 Mn |
| Dec 31, 2023 | 187.74 Mn |
| Sep 30, 2023 | 172.36 Mn |
| Jun 30, 2023 | 176.00 Mn |
| Mar 31, 2023 | 165.31 Mn |
| Dec 31, 2022 | 167.57 Mn |
| Sep 30, 2022 | 172.50 Mn |
| Jun 30, 2022 | 190.83 Mn |
| Mar 31, 2022 | 187.10 Mn |
| Dec 31, 2021 | 166.63 Mn |
| Sep 30, 2021 | 152.59 Mn |
| Jun 30, 2021 | 164.12 Mn |